Bortenat 3.5® Bortezomib Injection

Bortenat 3.5 mg contains bortezomib and is used to treat multiple myeloma and mantle cell lymphoma. It inhibits proteasome activity within cancer cells, interfering with their growth and survival

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.